Genpact director granted 6,521 RSUs

Verdi Mark A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Verdi Mark A reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director Mark A. Verdi reported a compensation-related share grant. He received 6,521 unvested restricted share units (RSUs), with each RSU representing one common share granted at no cash cost. These RSUs fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Following this award, Verdi directly holds 71,526 common shares.

Insider Trade Summary

Grant/Award: 6,521 shares

Grant/Award 1 txn

Insider Verdi Mark A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,521	$0.00	$0.00

Holdings After Transaction: Common Shares — 71,526 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Key Figures

RSU grant size: 6,521 shares Grant price: $0.0000 per share Shares held after grant: 71,526 shares +2 more

5 metrics

RSU grant size 6,521 shares Unvested restricted share units granted on April 23, 2026

Grant price $0.0000 per share Compensation award, no cash paid for RSUs

Shares held after grant 71,526 shares Total direct Genpact common shares following transaction

RSU vesting date December 31, 2026 RSUs fully vest subject to continued service

RSU settlement date December 31, 2027 RSUs settled in Genpact common shares

Key Terms

restricted share units (RSUs), Genpact Limited 2017 Omnibus Incentive Compensation Plan, unvested, settled in common shares

4 terms

restricted share units (RSUs) financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

Genpact Limited 2017 Omnibus Incentive Compensation Plan financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

unvested financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

settled in common shares financial

"the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Genpact (G) director Mark A. Verdi report in this Form 4 filing?

Genpact director Mark A. Verdi reported receiving 6,521 unvested restricted share units as a compensation award. Each RSU represents one common share, increasing his direct holdings to 71,526 common shares after the grant, with vesting and settlement tied to future dates.

How many Genpact (G) shares are covered by Mark A. Verdi’s new RSU award?

The new RSU award covers 6,521 restricted share units, each linked to one Genpact common share. These RSUs are unvested today and represent future share delivery, subject to vesting conditions tied to Verdi’s continued service with the company through the specified dates.

When do Mark A. Verdi’s Genpact RSUs vest and settle into common shares?

The RSUs will fully vest on December 31, 2026, assuming Mark A. Verdi’s continued service. After vesting, they will be settled in Genpact common shares on December 31, 2027, turning the restricted units into actual share ownership at that later settlement date.

Does Mark A. Verdi pay cash for the Genpact RSU grant reported in this filing?

No, the grant is recorded at a transaction price of $0.0000 per share, indicating a compensation award rather than a purchase. RSUs are typically granted as part of equity compensation, delivering value in company shares if vesting and settlement conditions are satisfied.

What is Mark A. Verdi’s Genpact share ownership after this RSU grant?

After the reported RSU award, Mark A. Verdi directly holds 71,526 Genpact common shares. This figure reflects his position following the 6,521-share RSU grant, as disclosed in the Form 4, and shows his ongoing equity exposure as a company director.

Under which plan were Mark A. Verdi’s Genpact RSUs granted?

The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. This plan provides for equity-based awards like restricted share units, aligning directors’ and employees’ interests with shareholders through future delivery of Genpact common shares upon vesting and settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 04:24 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verdi Mark A

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NEW YORK 10175

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/23/2026		A		6,521(1)	A	$0	71,526	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Mark Verdi	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)